The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan

Head Neck. 2022 Jun;44(6):1430-1441. doi: 10.1002/hed.27034. Epub 2022 Mar 29.

Abstract

Background: Salivary duct carcinoma (SDC) is a high-grade salivary malignancy that frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma. We herein examined the clinical factors affecting outcomes in a large cohort of SDC.

Methods: We selected 304 SDC cases and investigated clinical characteristics and the factors affecting outcomes.

Results: The median age of the cases examined was 68 years, the most common primary site was the parotid gland (238 cases), and there was a male predominance (M/F = 5:1). Outcomes were significantly worse when the primary tumor site was the minor salivary glands (SG) than when it was the major SG. Outcomes were also significantly worse in pN(+) cases (161 cases) than in pN0 cases, particularly those with a metastatic lymph node number ≥11. The cumulative incidence of relapse and distant metastases was significantly higher in stage IV cases than in stage 0-III cases.

Conclusions: The absolute number of lymph node metastases, higher stages, and the minor SG as the primary tumor site were identified as factors affecting the outcome of SDC.

Keywords: Japanese patient; competing-risk model; outcomes; salivary duct carcinoma.

Publication types

  • Multicenter Study

MeSH terms

  • Adenoma, Pleomorphic* / pathology
  • Aged
  • Carcinoma, Ductal* / surgery
  • Female
  • Humans
  • Japan
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Retrospective Studies
  • Salivary Ducts / pathology
  • Salivary Ducts / surgery
  • Salivary Gland Neoplasms* / pathology
  • Salivary Gland Neoplasms* / therapy